D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 59 Citations 17,322 111 World Ranking 5820 National Ranking 440

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Enzyme
  • Apoptosis

His main research concerns Tumor necrosis factor alpha, Cell biology, Receptor, Signal transduction and Apoptosis. His Tumor necrosis factor alpha research incorporates elements of Cytokine, Cell culture, Immune system and Programmed cell death. His study looks at the relationship between Programmed cell death and fields such as NFKB1, as well as how they intersect with chemical problems.

His work on NF-κB is typically connected to Context as part of general Cell biology study, connecting several disciplines of science. The study incorporates disciplines such as Molecular biology, Stimulation and Antigen in addition to Receptor. He studied Signal transduction and Cancer research that intersect with Caspase 8.

His most cited work include:

  • Tumor necrosis factor signaling. (1836 citations)
  • THE TRANSMEMBRANE FORM OF TUMOR NECROSIS FACTOR IS THE PRIME ACTIVATING LIGAND OF THE 80 KDA TUMOR NECROSIS FACTOR RECEPTOR (1112 citations)
  • NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling (547 citations)

What are the main themes of his work throughout his whole career to date?

Peter Scheurich mainly investigates Tumor necrosis factor alpha, Cell biology, Receptor, Apoptosis and Signal transduction. The concepts of his Tumor necrosis factor alpha study are interwoven with issues in Molecular biology, Cancer research, Antibody and Cytokine. He combines subjects such as Cell, Fas ligand, Fas receptor, FADD and Death domain with his study of Cell biology.

His Endocrinology research extends to Receptor, which is thematically connected. His work carried out in the field of Apoptosis brings together such families of science as Crosstalk and Signalling. His Signal transduction research is multidisciplinary, incorporating perspectives in Kinase, Protein kinase A, Downregulation and upregulation, Transcription factor and Tumor Necrosis Factor Receptor-Associated Factors.

He most often published in these fields:

  • Tumor necrosis factor alpha (46.05%)
  • Cell biology (41.45%)
  • Receptor (36.18%)

What were the highlights of his more recent work (between 2006-2021)?

  • Cell biology (41.45%)
  • Tumor necrosis factor alpha (46.05%)
  • Apoptosis (26.32%)

In recent papers he was focusing on the following fields of study:

Peter Scheurich mostly deals with Cell biology, Tumor necrosis factor alpha, Apoptosis, Signal transduction and Receptor. His Cell biology study combines topics from a wide range of disciplines, such as Fas ligand, Programmed cell death, Death domain and Immune system. His Tumor necrosis factor alpha study improves the overall literature in Immunology.

His Apoptosis study incorporates themes from Cell, Downregulation and upregulation and Crosstalk. His Signal transduction research includes elements of Transcription factor, Neurodegeneration, Molecular biology, FADD and Internalization. His Receptor research entails a greater understanding of Biochemistry.

Between 2006 and 2021, his most popular works were:

  • TNFR1‐induced activation of the classical NF‐κB pathway (172 citations)
  • ON/OFF and Beyond - A Boolean Model of Apoptosis (147 citations)
  • Single-Chain TNF, a TNF Derivative with Enhanced Stability and Antitumoral Activity (82 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Enzyme
  • Apoptosis

His primary areas of investigation include Tumor necrosis factor alpha, Cell biology, Signal transduction, Immunology and Receptor. His Tumor necrosis factor alpha research is multidisciplinary, incorporating elements of Humanized antibody, Tissue homeostasis, Cytokine and Fragment crystallizable region. His studies in Cell biology integrate themes in fields like Inhibitor of apoptosis, Apoptosis, Programmed cell death and TRADD.

He has researched Apoptosis in several fields, including Transcription factor and Neuroscience. His Signal transduction study is concerned with Biochemistry in general. The various areas that Peter Scheurich examines in his Receptor study include Extracellular, Cell membrane and Binding site.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Tumor necrosis factor signaling.

H Wajant;K Pfizenmaier;P Scheurich.
Cell Death & Differentiation (2003)

2736 Citations

THE TRANSMEMBRANE FORM OF TUMOR NECROSIS FACTOR IS THE PRIME ACTIVATING LIGAND OF THE 80 KDA TUMOR NECROSIS FACTOR RECEPTOR

Matthias Grell;Eleni Douni;Harald Wajant;Matthias Löhden.
Cell (1995)

1548 Citations

NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling

Sebastian Kreuz;Daniela Siegmund;Peter Scheurich;Harald Wajant.
Molecular and Cellular Biology (2001)

718 Citations

Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses

P Scheurich;B Thoma;U Ucer;K Pfizenmaier.
Journal of Immunology (1987)

660 Citations

The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor

Matthias Grell;Harald Wajant;Gudrun Zimmermann;Peter Scheurich.
Proceedings of the National Academy of Sciences of the United States of America (1998)

527 Citations

The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators.

Harald Wajant;Frank Henkler;Peter Scheurich.
Cellular Signalling (2001)

417 Citations

Bistability Analyses of a Caspase Activation Model for Receptor-induced Apoptosis

Thomas Eissing;Holger Conzelmann;Ernst Dieter Gilles;Ernst Dieter Gilles;Frank Allgöwer.
Journal of Biological Chemistry (2004)

366 Citations

Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF‐R1 activation by endogenous membrane‐anchored TNF

Matthias Grell;Gudrun Zimmermann;Eva Gottfried;Chun Ming Chen;Chun Ming Chen.
The EMBO Journal (1999)

358 Citations

Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system.

Günther Eissner;Walter Kolch;Peter Scheurich.
Cytokine & Growth Factor Reviews (2004)

343 Citations

Tumor necrosis factor enhances HLA-A,B,C and HLA-DR gene expression in human tumor cells.

K Pfizenmaier;P Scheurich;C Schlüter;M Krönke.
Journal of Immunology (1987)

328 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Peter Scheurich

Harald Wajant

Harald Wajant

University of Würzburg

Publications: 94

Klaus Pfizenmaier

Klaus Pfizenmaier

University of Stuttgart

Publications: 50

Frank Allgöwer

Frank Allgöwer

University of Stuttgart

Publications: 37

Roland E. Kontermann

Roland E. Kontermann

University of Stuttgart

Publications: 36

Henning Walczak

Henning Walczak

University College London

Publications: 35

Sergei A. Nedospasov

Sergei A. Nedospasov

Engelhardt Institute of Molecular Biology

Publications: 34

Peter Vandenabeele

Peter Vandenabeele

Ghent University

Publications: 34

George Kollias

George Kollias

National and Kapodistrian University of Athens

Publications: 33

David Wallach

David Wallach

Weizmann Institute of Science

Publications: 32

Peter H. Krammer

Peter H. Krammer

German Cancer Research Center

Publications: 30

Marcus E. Peter

Marcus E. Peter

Northwestern University

Publications: 26

John Silke

John Silke

Walter and Eliza Hall Institute of Medical Research

Publications: 26

Hideo Yagita

Hideo Yagita

Juntendo University

Publications: 25

Pascal Schneider

Pascal Schneider

University of Lausanne

Publications: 24

Yasuo Tsutsumi

Yasuo Tsutsumi

Osaka University

Publications: 23

Martin Leverkus

Martin Leverkus

RWTH Aachen University

Publications: 22

Trending Scientists

Qilin Cheng

Qilin Cheng

East China University of Science and Technology

James P. Crutchfield

James P. Crutchfield

University of California, Davis

Hua Fu

Hua Fu

Tsinghua University

Zheshuai Lin

Zheshuai Lin

Chinese Academy of Sciences

Maria Z. Tsimidou

Maria Z. Tsimidou

Aristotle University of Thessaloniki

Andrew Whiting

Andrew Whiting

Durham University

Brenda N. Bonnett

Brenda N. Bonnett

University of Guelph

Paul C. D. Newton

Paul C. D. Newton

AgResearch

Yoh Wada

Yoh Wada

Osaka University

Shiaw-Min Hwang

Shiaw-Min Hwang

Rutgers, The State University of New Jersey

Siegfried Scherer

Siegfried Scherer

Technical University of Munich

Jasper Berndt

Jasper Berndt

University of Münster

Jeffrey D. Schall

Jeffrey D. Schall

Vanderbilt University

W. M. Cowan

W. M. Cowan

Washington University in St. Louis

Daniel H. Teitelbaum

Daniel H. Teitelbaum

University of Michigan–Ann Arbor

Dasaratha V. Rama

Dasaratha V. Rama

Florida International University

Something went wrong. Please try again later.